Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial.
Kopin D, Jones WS, Sherwood MW, Wojdyla DM, Wallentin L, Lewis BS, Verheugt FWA, Vinereanu D, Bahit MC, Halvorsen S, Huber K, Parkhomenko A, Granger CB, Lopes RD, Alexander JH. Kopin D, et al. Among authors: jones ws. Am Heart J. 2018 Mar;197:133-141. doi: 10.1016/j.ahj.2017.11.005. Epub 2017 Nov 10. Am Heart J. 2018. PMID: 29447773 Clinical Trial.
Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery.
Harskamp RE, Alexander JH, Schulte PJ, Jones WS, Williams JB, Mack MJ, Peterson ED, Gibson CM, Califf RM, Kouchoukos NT, Ferguson TB, de Winter RJ, Lopes RD. Harskamp RE, et al. Among authors: jones ws. Ann Thorac Surg. 2014 Mar;97(3):824-30. doi: 10.1016/j.athoracsur.2013.09.099. Epub 2013 Dec 21. Ann Thorac Surg. 2014. PMID: 24360877 Free PMC article.
Dual antiplatelet therapy with or without oral anticoagulation in the postdischarge management of acute coronary syndrome patients with an indication for long term anticoagulation: a systematic review.
Washam JB, Dolor RJ, Jones WS, Halim SA, Hasselblad V, Mayer SB, Heidenfelder BL, Melloni C. Washam JB, et al. Among authors: jones ws. J Thromb Thrombolysis. 2014 Oct;38(3):285-98. doi: 10.1007/s11239-014-1094-1. J Thromb Thrombolysis. 2014. PMID: 24891133 Review.
Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER).
Jones WS, Tricoci P, Huang Z, Moliterno DJ, Harrington RA, Sinnaeve PR, Strony J, Van de Werf F, White HD, Held C, Armstrong PW, Aylward PE, Chen E, Patel MR, Mahaffey KW. Jones WS, et al. Am Heart J. 2014 Oct;168(4):588-96. doi: 10.1016/j.ahj.2014.06.017. Epub 2014 Jul 4. Am Heart J. 2014. PMID: 25262270 Clinical Trial.
323 results